10th Edition of World Congress on Infectious Diseases
June 25-27, 2026 | Barcelona, Spain
Exogenous Retroviruses
Exogenous retroviruses represent a fascinating class of viruses that have integrated into the genome of their host organisms. These viruses, characterized by their unique ability to reverse transcribe their RNA genome into DNA, have left an indelible mark on the evolution of various species. One notable example is the human immunodeficiency virus (HIV), responsible for acquired immunodeficiency syndrome (AIDS). HIV, having zoonotic origins, likely jumped from non-human primates to humans in Central Africa. The virus's integration into the human genome has raised intriguing questions about the impact of exogenous retroviruses on human evolution and susceptibility to certain diseases. Research into these viruses extends beyond human health, encompassing diverse organisms, from plants to animals, where exogenous retroviruses have influenced genetic diversity and adaptation over millions of years.
Francis J Castellino
University of Notre Dame, United States
Ranjan Ramasamy
ID-FISH Technology, United States
Yazdan Mirzanejad
University of British Columbia, Canada
Alexis Torres Rodriguez
NewYork-Presbyterian Queens Hospital, United States
Sasha Leibholz
New York Presbyterian Columbia/Cornell, United States
Hana Raza
Mclaren Oakland Hospital, United States
Terri Menser
Mayo Clinic, United StatesSubmit your abstract Today
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation